透過您的圖書館登入
IP:3.138.114.94
  • 學位論文

開發不易形成體脂肪之紅麴保健食品

Development of Monascus Functional Food for the Prevention of Fat Accumulation

指導教授 : 潘子明

摘要


肥胖是導致心血管疾病與糖尿病之危險因子,本研究利用體外細胞實驗及活體動物實驗評估紅麴米及紅麴山藥對體脂肪生成之影響。體外模式以 3T3-L1 前脂肪細胞株作為試驗材料,探討紅麴米及紅麴山藥萃取物對前脂肪細胞增生、分化之影響,並分析成熟脂肪細胞脂解作用 (lipolysis) 及脂蛋白脂解酶 (lipoprotein lipase, LPL) 活性之變化。體內評估部分以雄性 Wistar 大白鼠作為試驗動物,研究中同時餵食高油脂飼料與紅麴發酵產物,飼養 6 週後,利用各項評估指標判定其減少體脂肪生成之效果。細胞實驗結果顯示,紅麴米水萃取物、乙醇萃取物與紅麴山藥乙醇萃取物皆具有抑制前脂肪細胞增生、分化之效果;紅麴山藥水萃取物僅具抑制分化作用。紅麴米及紅麴山藥水萃取物皆可提高 lipolysis 效率,其中以紅麴米之效果較佳。紅麴山藥乙醇萃取物能抑制脂肪細胞肝素釋放脂蛋白脂解酶 (heparin-releasable LPL, HR-LPL) 活性。動物實驗結果顯示,於高油脂飲食中添加 0.4%、2% (w/w) 紅麴米能顯著抑制腎臟及副睪周圍脂肪細胞增大,改善脂肪組織堆積情形,並且可減緩體重上升,其可能因素包括提高腎臟及副睪周圍脂肪組織 lipolysis 效率及減少攝食量。紅麴山藥僅在高劑量組 (2%, w/w) 有明顯抑制脂肪細胞增大及體重上升之效果,這個效果可能與提高副睪周圍脂肪組織 lipolysis 效率、抑制腎臟周圍脂肪組織 HR-LPL 活性及減少攝食量有關。雖然在本研究之動物模式中,紅麴發酵產物之功效主要來自於抑制脂肪細胞增大,但其仍具有抑制前脂肪細胞增生及分化之影響,可避免過多的脂肪細胞生成。Monacolin K (lovastatin) 能降低大鼠攝食量,抑制副睪周圍脂肪細胞增大,並且有抑制前脂肪細胞增生之效果,可能是紅麴發酵產物的功能性成分之ㄧ。另外,餵食紅麴發酵產物可降低高油脂飲食大鼠血中總膽固醇、低密度脂蛋白膽固醇 (low density lipoprotein cholesterol, LDL-C) 及胰島素濃度,對於肝臟脂質、血糖及血液生化值無顯著影響。本研究首次提出紅麴發酵產物能夠改善高油脂飲食引起之體脂肪堆積、血脂紊亂及高血胰島素症狀,有潛力發展為不易形成體脂肪之保健食品。

並列摘要


Obesity is associated with high risk for developing cardiovascular disease and diabetes. In this study, we used 3T3-L1 cell line as in vitro model to examin the effects of extracts of red mold rice (RMR) and red mold dioscorea (RMD) on proliferation and differentiation in preadipocyte as well as lipolysis and heparin-releasable lipoprotein lipase activity in mature adipocyte. Furthermore, we also investigated the in vivo antiobesity effects of Monascus fermented products by animal experiment. Male Wistar rats were fed high-fat diet (HF) and Monascus fermented products at the same time. After six weeks, rats were sacrificed for evaluation. As results in cellular experiment, ethanol extracts of RMR and RMD and water extract of RMD had inhibitive effects on 3T3-L1 preadipocyte proliferation and differentiation. However, water extract of RMD was not able to affect preadipocyte proliferation but reduce the triglyceride content in cell during adipogenesis. The water extracts but not ethanol extracts of RMR or RMD could induce lipolysis in mature adipocyte, and RMR water extract had stronger effect. 3T3-L1 adipocyte treated with the ethanol extract of RMD had lower heparin-releasable LPL (HR-LPL) activity. In animal experiment, rats fed HF diet supplemented with 0.4% and 2% (w/w) RMR had less perirenal and epididymal fat pads, moreover the weight gain were significantly decreased compared with HF control. These effects probably resulted from reducing calorie intake as well as increasing lipolysis activity in perirenal and epididymal adipose tissues. Rats fed with high dose RMD (2%, w/w) also had less adipose tissue mass and weight gain. Stimulating lipolysis in epididymal fat pads and lowering HR-LPL activity in perierenal fat pads as well as decreasing calorie intake might illustrate the influence of high dose RMD. In our animal model, the major effect of Monascus fermented products was inhibiting hypertrophy in adipocyte. However, the Monascus fermented products had inhibitive effects on proliferation and differentiation in preadipocyte, which could avoid fat cell formation. Monacoin K (lovastatin) had inhibitive effects on food intake and differentiation in 3T3-L1 preadipocyte, which may be one of the functional ingredients in Monascus fermented products. On the other hand, rat fed Monascus fermented products had lower serum total cholesterol, low density lipoprotein cholesterol (LDL-C) and insulin while hepatic lipids and serum parameters without any significant difference. This study reveals for the first time that Monascus fermented products could prevent body fat accumulation and improve dyslipidemia and hyperinsulinemia induced by high-fat diet, which has potential to be an antiobesity functional food.

參考文獻


洪雅雯。2006。山苦瓜改善高油高糖餵食大鼠腹部體脂肪堆積及胰島素抗性 (碩士論文)。
Lee, C. L., Wang, J. J., and Pan, T. M. 2006c. Synchronous analysis method for detection of citrinin and the lactone and acid forms of monacolin K in red mold rice. J. AOAC Int. 89: 669-677.
Ahima, R. S., and Flier, J. S. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11: 327-332.
Albert, A.W., Chen, J., and Springer, J. 1980. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol -lowing agent. Proc. Natl. Acad. Sci. USA. 77:3957-3961.
Anderson, J. W., Kendall, C. W. C., and Jenkins, D. J. A. 2003. Importance of weight management in type 2 diabetes: Review with meta-analysis of clinical studies. J. Am. Coll. Nutr. 22:331–339.

被引用紀錄


陳盈伊(2015)。Bis-demethoxycurcumin (BDMC) 抑制脂肪細胞新生作用 及減緩高脂飼料誘導之肥胖〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2015.00708
周珮祺(2010)。紅麴二次代謝物 monascin 與 ankaflavin 對 3T3-L1脂肪細胞新生作用與脂解作用之探討〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2010.00503

延伸閱讀